{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:55:10Z","timestamp":1761252910464},"reference-count":144,"publisher":"Frontiers Media SA","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":439,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1111\/tri.12360","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T10:44:36Z","timestamp":1400841876000},"page":"877-891","source":"Crossref","is-referenced-by-count":20,"title":["Hepatitis C virus infection in end-stage renal disease and kidney transplantation"],"prefix":"10.3389","volume":"27","author":[{"given":"Patrizia","family":"Burra","sequence":"first","affiliation":[{"name":"Multivisceral Transplant Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kryssia I.","family":"Rodr\u00edguez-Castro","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Marchini","sequence":"additional","affiliation":[{"name":"Unit of Nephrology and Dialysis; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Bonfante","sequence":"additional","affiliation":[{"name":"Unit of Nephrology and Dialysis; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrezia","family":"Furian","sequence":"additional","affiliation":[{"name":"Kidney and Pancreas Transplantation Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ferrarese","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zanetto","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Germani","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Paolo","family":"Russo","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"10.1111\/tri.12360-BIB0001|tri12360-cit-0001","unstructured":"World Health Organization Hepatitis C http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/2014"},{"key":"10.1111\/tri.12360-BIB0002|tri12360-cit-0002","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1016\/j.ijid.2011.04.001","article-title":"Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy","volume":"15","author":"Li","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1111\/tri.12360-BIB0003|tri12360-cit-0003","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00007890-199204000-00011","article-title":"The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients","volume":"53","author":"Huang","year":"1992","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0004|tri12360-cit-0004","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00007890-199306000-00014","article-title":"Hepatitis C is a poor prognostic indicator in black kidney transplant recipients","volume":"55","author":"Fritsche","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0005|tri12360-cit-0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0272-6386(95)90617-7","article-title":"Hepatitis C virus: the nephrologist's view","volume":"25","author":"Roth","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0006|tri12360-cit-0006","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007890-199510000-00007","article-title":"The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation","volume":"60","author":"Periera","year":"1995","journal-title":"Transplantation"},{"issue":"1 Pt 2","key":"10.1111\/tri.12360-BIB0007|tri12360-cit-0007","first-page":"1466","article-title":"Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival-a 5- and 10-year follow-up","volume":"25","author":"Ynares","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12360-BIB0008|tri12360-cit-0008","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00007890-199302000-00008","article-title":"Hepatitis C-its prevalence in end-stage renal failure patients and clinical course after kidney transplantation","volume":"55","author":"Stempel","year":"1993","journal-title":"Transplantation"},{"issue":"1 Pt 2","key":"10.1111\/tri.12360-BIB0009|tri12360-cit-0009","first-page":"1371","article-title":"Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation","volume":"23","author":"Ponz","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12360-BIB0010|tri12360-cit-0010","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/ndt\/gfi159","article-title":"ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends","volume":"20","author":"Grassmann","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0011|tri12360-cit-0011","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/ndt\/17.12.2071","article-title":"ESRD patients in 2001: global overview of patients, treatment modalities and development trends","volume":"17","author":"Moeller","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0012|tri12360-cit-0012","unstructured":"Global Observatory on Donation and Transplantation http:\/\/wwwtransplant-observatoryorg\/Pages\/Data-Reportsaspx2014"},{"issue":"Suppl. 48","key":"10.1111\/tri.12360-BIB0013|tri12360-cit-0013","first-page":"S5","article-title":"The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report","volume":"26","author":"Antonucci","year":"2009","journal-title":"G Ital Nefrol"},{"key":"10.1111\/tri.12360-BIB0014|tri12360-cit-0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/039139880803100104","article-title":"Hepatitis C infection in patients with chronic kidney disease","volume":"31","author":"Mangia","year":"2008","journal-title":"Int J Artif Organs"},{"key":"10.1111\/tri.12360-BIB0015|tri12360-cit-0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ndt\/14.1.40","article-title":"Hepatitis virus infection in haemodialysis patients from Moldavia","volume":"14","author":"Covic","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0016|tri12360-cit-0016","first-page":"1","article-title":"[Prevalence of hepatitis B and C viruses in a chronic hemodialysis center in Dakar]","volume":"45","author":"Diouf","year":"2000","journal-title":"Dakar Med"},{"key":"10.1111\/tri.12360-BIB0017|tri12360-cit-0017","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1681\/ASN.2006070736","article-title":"Hepatitis C virus and death risk in hemodialysis patients","volume":"18","author":"Kalantar-Zadeh","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0018|tri12360-cit-0018","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/ndt\/gfh012","article-title":"The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study","volume":"19","author":"Jadoul","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0019|tri12360-cit-0019","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0272-6386(97)90345-0","article-title":"The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients","volume":"29","author":"Knoll","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0020|tri12360-cit-0020","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"109","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1111\/tri.12360-BIB0021|tri12360-cit-0021","unstructured":"Alter MJ Lyearla RL Tokars JI et\u00a0al Recommendations for preventing transmission of infections among chronic hemodialysis patients http:\/\/wwwcdcgov\/mmwr\/preview\/mmwrhtml\/rr5005a1htm2001"},{"key":"10.1111\/tri.12360-BIB0022|tri12360-cit-0022","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/tri.12360-BIB0023|tri12360-cit-0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gut.51.3.429","article-title":"Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients","volume":"51","author":"Hinrichsen","year":"2002","journal-title":"Gut"},{"key":"10.1111\/tri.12360-BIB0024|tri12360-cit-0024","doi-asserted-by":"crossref","first-page":"e9147","DOI":"10.5812\/hepatmon.9147","article-title":"Hepatitis C virus (HCV) infection rate among seronegative hemodialysis patients screened by two methods; HCV core antigen and polymerase chain reaction","volume":"13","author":"Moini","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1111\/tri.12360-BIB0025|tri12360-cit-0025","first-page":"832021","article-title":"Hepatitis C virus core antigen test in monitoring of dialysis patients","volume":"2012","author":"Li","year":"2012","journal-title":"Hepat Res Treat"},{"key":"10.1111\/tri.12360-BIB0026|tri12360-cit-0026","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/JCM.43.1.414-420.2005","article-title":"Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients","volume":"43","author":"Fabrizi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/tri.12360-BIB0027|tri12360-cit-0027","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5858\/2002-126-0285-MTITDA","article-title":"Molecular testing in the diagnosis and management of hepatitis C virus infection","volume":"126","author":"Podzorski","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/tri.12360-BIB0028|tri12360-cit-0028","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1537-2995.1992.32592327714.x","article-title":"Impact of specimen handling and storage on detection of hepatitis C virus RNA","volume":"32","author":"Busch","year":"1992","journal-title":"Transfusion"},{"key":"10.1111\/tri.12360-BIB0029|tri12360-cit-0029","first-page":"73","article-title":"Patterns of hepatitis C viremia in patients receiving hemodialysis","volume":"92","author":"Umlauft","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/tri.12360-BIB0030|tri12360-cit-0030","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1023\/A:1026696721059","article-title":"Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10-year study","volume":"45","author":"Furusyo","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1111\/tri.12360-BIB0031|tri12360-cit-0031","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1023\/A:1018813532098","article-title":"Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases","volume":"42","author":"Montalto","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1111\/tri.12360-BIB0032|tri12360-cit-0032","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1478-3231.1999.tb00018.x","article-title":"Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels","volume":"19","author":"Puoti","year":"1999","journal-title":"Liver"},{"key":"10.1111\/tri.12360-BIB0033|tri12360-cit-0033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TP.0b013e318294cad1","article-title":"Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients","volume":"96","author":"Kim","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0034|tri12360-cit-0034","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/j.1572-0241.1999.01649.x","article-title":"Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation","volume":"94","author":"Sterling","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/tri.12360-BIB0035|tri12360-cit-0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004836-200208000-00013","article-title":"Characteristics of hepatitis C in renal transplant candidates","volume":"35","author":"Cotler","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/tri.12360-BIB0036|tri12360-cit-0036","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1046\/j.1523-1755.1999.00791.x","article-title":"Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor","volume":"56","author":"Rampino","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12360-BIB0037|tri12360-cit-0037","first-page":"157","article-title":"Does end-stage kidney failure influence hepatitis C progression in hemodialysis patients?","volume":"50","author":"Luzar","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/tri.12360-BIB0038|tri12360-cit-0038","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02550322","article-title":"Hepatitis C in haemodialysis and nonuraemic patients: a histopathological study","volume":"30","author":"Akpolat","year":"1998","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/tri.12360-BIB0039|tri12360-cit-0039","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000045215","article-title":"Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey","volume":"80","author":"Fabrizi","year":"1998","journal-title":"Nephron"},{"key":"10.1111\/tri.12360-BIB0040|tri12360-cit-0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0272-6386(03)00417-7","article-title":"Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena?","volume":"42","author":"Badalamenti","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0041|tri12360-cit-0041","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"Scott","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0042|tri12360-cit-0042","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2893.2007.00853.x","article-title":"Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis","volume":"14","author":"Butt","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1111\/tri.12360-BIB0043|tri12360-cit-0043","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/089686080802800215","article-title":"Mortality in hepatitis C-positive patients treated with peritoneal dialysis","volume":"28","author":"Wang","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1111\/tri.12360-BIB0044|tri12360-cit-0044","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","article-title":"Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"14","author":"Goodkin","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0045|tri12360-cit-0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2893.2007.00868.x","article-title":"The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies","volume":"14","author":"Fabrizi","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1111\/tri.12360-BIB0046|tri12360-cit-0046","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2893.2012.01633.x","article-title":"Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?","volume":"19","author":"Fabrizi","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1111\/tri.12360-BIB0047|tri12360-cit-0047","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1681\/ASN.V11101896","article-title":"Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy","volume":"11","author":"Nakayama","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0048|tri12360-cit-0048","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/ndt\/16.8.1669","article-title":"Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients","volume":"16","author":"Espinosa","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0049|tri12360-cit-0049","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.V9122244","article-title":"Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"9","author":"Markowitz","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0050|tri12360-cit-0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00007890-199803150-00011","article-title":"Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients","volume":"65","author":"Legendre","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0051|tri12360-cit-0051","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/01.TP.0000131948.29742.24","article-title":"Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation","volume":"78","author":"Bruchfeld","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0052|tri12360-cit-0052","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/ndt\/gfm678","article-title":"Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts","volume":"23","author":"Weclawiack","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0053|tri12360-cit-0053","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-6143.2003.30113.x","article-title":"Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy","volume":"3","author":"Baid","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12360-BIB0054|tri12360-cit-0054","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection","volume":"59","author":"Magnone","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0055|tri12360-cit-0055","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000189444","article-title":"Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C","volume":"74","author":"Rostaing","year":"1996","journal-title":"Nephron"},{"key":"10.1111\/tri.12360-BIB0056|tri12360-cit-0056","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/tri.12360-BIB0057|tri12360-cit-0057","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.2013.264","article-title":"Hepatitis C treatment in patients with kidney disease","volume":"84","author":"Fabrizi","year":"2013","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12360-BIB0058|tri12360-cit-0058","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1681\/ASN.2010060668","article-title":"Effect of kidney transplantation on outcomes among patients with hepatitis C","volume":"22","author":"Roth","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0059|tri12360-cit-0059","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jir.1981.1.347","article-title":"Renal filtration, absorption and catabolism of human alpha interferon","volume":"1","author":"Bocci","year":"1981","journal-title":"J Interferon Res"},{"issue":"Suppl. 1","key":"10.1111\/tri.12360-BIB0060|tri12360-cit-0060","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.dld.2014.01.031","article-title":"Early virological response is the main predictor of viral eradication in HCV haemodialysis patients treated with pegylated interferon plus ribavirin","volume":"46","author":"Tucci","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"Suppl. 1","key":"10.1111\/tri.12360-BIB0061|tri12360-cit-0061","first-page":"17","article-title":"The clinical pharmacology of ribavirin","volume":"19","author":"Glue","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1111\/tri.12360-BIB0062|tri12360-cit-0062","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127002401382713","article-title":"Single-dose pharmacokinetics and safety of pegylated interferon-alpha2b in patients with chronic renal dysfunction","volume":"42","author":"Gupta","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/tri.12360-BIB0063|tri12360-cit-0063","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2893.2008.00990.x","article-title":"Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials","volume":"15","author":"Fabrizi","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1111\/tri.12360-BIB0064|tri12360-cit-0064","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2007.11.003","article-title":"Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms","volume":"51","author":"Gordon","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0065|tri12360-cit-0065","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1365-2893.2010.01405.x","article-title":"Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials","volume":"18","author":"Fabrizi","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1111\/tri.12360-BIB0066|tri12360-cit-0066","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ndt\/gfm724","article-title":"Pegylated interferon alfa-2a (40\u00a0kD) and ribavirin in haemodialysis patients with chronic hepatitis C","volume":"23","author":"Leusen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0067|tri12360-cit-0067","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2006.12.016","article-title":"The treatment of chronic hepatitis C with peginterferon alfa-2a (40\u00a0kDa) plus ribavirin in haemodialysed patients awaiting renal transplant","volume":"46","author":"Rendina","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12360-BIB0068|tri12360-cit-0068","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.transproceed.2004.07.025","article-title":"Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C","volume":"36","author":"Mousa","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12360-BIB0069|tri12360-cit-0069","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2893.2005.00680.x","article-title":"Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients","volume":"13","author":"Bruchfeld","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1111\/tri.12360-BIB0070|tri12360-cit-0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF03261935","article-title":"Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function","volume":"51","author":"Treitel","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/tri.12360-BIB0071|tri12360-cit-0071","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.26602","article-title":"Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir","volume":"59","author":"Mauss","year":"2014","journal-title":"Hepatology"},{"key":"10.1111\/tri.12360-BIB0072|tri12360-cit-0072","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcv.2012.10.009","article-title":"Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?","volume":"56","author":"Dumortier","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1111\/tri.12360-BIB0073|tri12360-cit-0073","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1208809","article-title":"Exploratory study of oral combination antiviral therapy for hepatitis C","volume":"368","author":"Poordad","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12360-BIB0074|tri12360-cit-0074","unstructured":"Antiviral Drugs Advisory Committee Meeting G Sofosbuvir for Treatment of Chronic Hepatitis C Infection http:\/\/wwwfdagov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/drugs\/antiviraldrugsadvisorycommittee\/ucm371877pdf)2013October25"},{"issue":"Suppl. 1","key":"10.1111\/tri.12360-BIB0075|tri12360-cit-0075","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0168-8278(12)60115-9","article-title":"SVR4 and SVR12 with an Interferon-free regimen of BI201335 and BI207127, +\/\u2212 ribavirin, in treatment-naive patients with chronic genotype-1 HCV infection: interim results of SOUND-C2","volume":"56","author":"Zeuzem","year":"2012","journal-title":"J Hepatol"},{"issue":"Suppl. 2","key":"10.1111\/tri.12360-BIB0076|tri12360-cit-0076","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1016\/S0168-8278(12)61431-7","article-title":"The efficacy and safety of the interferon-free combination of BI201335 and BI207127 in genotype 1 HCV patients with cirrhosis - Interim Analysis from SOUND-C2","volume":"56","author":"Soriano","year":"2012","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1111\/tri.12360-BIB0077|tri12360-cit-0077","first-page":"00","article-title":"A 12-week interferon-free treatment regimen with ABT-450\/r, ABT-267, ABT-333 and ribavirin achieves SVR rates (observed data) of 99% in treatment-naive patients and 93% in prior null responders with HCV genotype 1 infection","volume":"56","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1111\/tri.12360-BIB0078|tri12360-cit-0078","doi-asserted-by":"crossref","first-page":"S570","DOI":"10.1016\/S0168-8278(13)61416-6","article-title":"Sustained virologic response with daclatasvir plus sofosbuvir\u00a0\u00b1\u00a0ribavirin (RBV) in chronic HCV genotype (GT) 1-infected patients who previously failed telaprevir (TVR) or boceprevir (BOC)","volume":"58","author":"Sulkowski","year":"2013","journal-title":"J Hepatol"},{"issue":"Suppl.","key":"10.1111\/tri.12360-BIB0079|tri12360-cit-0079","first-page":"1379A","article-title":"SVR results of a once-daily regimen of simeprevir (TMC435) plus sofosbuvir (GS-7977) with or without ribavirin in cirrhotic and non-cirrhotic HCV genotype 1 traetment-na\u00efve and prior null responder patients: the COSMOS study","volume":"58","author":"Jacobson","year":"2013","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1111\/tri.12360-BIB0080|tri12360-cit-0080","first-page":"244","article-title":"High efficacy and safety of the all-oral combination regimen, MK-5172\/MK-8742\u00a0+\u00a0\/\u2212 RBV for 12\u00a0weeks in HCV genotype 1 infected patients: The C-WORTHY Study","volume":"58","author":"Lawitz","year":"2013","journal-title":"Hepatology"},{"key":"10.1111\/tri.12360-BIB0081|tri12360-cit-0081","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/ajkd.2001.28576","article-title":"Hepatitis C virus infection and renal transplantation","volume":"38","author":"Fabrizi","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0082|tri12360-cit-0082","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0016-5085(93)91023-B","article-title":"A prospective study of hepatitis C virus infection among renal transplant recipients","volume":"104","author":"Chan","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1111\/tri.12360-BIB0083|tri12360-cit-0083","first-page":"943","article-title":"Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation","volume":"27","author":"Zucker","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12360-BIB0084|tri12360-cit-0084","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/hep.1840180305","article-title":"Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients","volume":"18","author":"Lok","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/tri.12360-BIB0085|tri12360-cit-0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jmv.1890440109","article-title":"Hepatitis C virus infections in transplant patients: serological and virological investigations","volume":"44","author":"Maple","year":"1994","journal-title":"J Med Virol"},{"key":"10.1111\/tri.12360-BIB0086|tri12360-cit-0086","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.1840180502","article-title":"Hepatitis C virus infection in kidney transplant recipients","volume":"18","author":"Lau","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/tri.12360-BIB0087|tri12360-cit-0087","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/00007890-199712270-00026","article-title":"Serologic responses to hepatitis C virus in solid organ transplant recipients","volume":"64","author":"Preiksaitis","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0088|tri12360-cit-0088","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/S0041-1345(99)00691-0","article-title":"Organ-transmitted HCV infection in kidney transplant recipients from an anti-HCV negative donor","volume":"31","author":"Nampoory","year":"1999","journal-title":"Transplant Proc"},{"issue":"4 Pt 2","key":"10.1111\/tri.12360-BIB0089|tri12360-cit-0089","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1399-0012.2000.14040602.x","article-title":"Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors","volume":"14","author":"Mandal","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.12360-BIB0090|tri12360-cit-0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0012.2002.00101.x","article-title":"Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers","volume":"16","author":"Batiuk","year":"2002","journal-title":"Clin Transplant"},{"issue":"Suppl. 8","key":"10.1111\/tri.12360-BIB0091|tri12360-cit-0091","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ndt\/15.suppl_8.71","article-title":"Policies concerning the use of kidneys from donors infected with hepatitis C virus","volume":"15","author":"Morales","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0092|tri12360-cit-0092","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/00007890-199812270-00021","article-title":"Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation","volume":"66","author":"Ali","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0093|tri12360-cit-0093","unstructured":"Oldach D Constantine N Schweister E Clinical and virological outcomes in hepatitis C virus (HCV)-infected renal transplant recipients 1995"},{"key":"10.1111\/tri.12360-BIB0094|tri12360-cit-0094","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007890-199510150-00004","article-title":"Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney","volume":"60","author":"Widell","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0095|tri12360-cit-0095","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1523-1755.1999.00594.x","article-title":"Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group","volume":"56","author":"Natov","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12360-BIB0096|tri12360-cit-0096","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1111\/ajt.12400","article-title":"Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient","volume":"13","author":"Cruzado","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12360-BIB0097|tri12360-cit-0097","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.510290123","article-title":"Impact of hepatitis B and C virus on kidney transplantation outcome","volume":"29","author":"Mathurin","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/tri.12360-BIB0098|tri12360-cit-0098","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2003.09.018","article-title":"The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study","volume":"43","author":"Mahmoud","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0099|tri12360-cit-0099","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/TP.0b013e3182848de2","article-title":"Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis","volume":"95","author":"Ingsathit","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0100|tri12360-cit-0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ki.1994.29","article-title":"The impact of hepatitis C virus infection on renal allograft recipients","volume":"45","author":"Roth","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12360-BIB0101|tri12360-cit-0101","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.V1171343","article-title":"Transplantation in the patient with hepatitis C","volume":"11","author":"Morales","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"5 Suppl. 1","key":"10.1111\/tri.12360-BIB0102|tri12360-cit-0102","first-page":"S3","article-title":"National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002-June 10-12, 2002","volume":"36","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/tri.12360-BIB0103|tri12360-cit-0103","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1086\/315355","article-title":"Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients","volume":"181","author":"Izopet","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.12360-BIB0104|tri12360-cit-0104","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1600-6143.2005.00918.x","article-title":"Natural history of hepatitis C virus-related liver fibrosis after renal transplantation","volume":"5","author":"Kamar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12360-BIB0105|tri12360-cit-0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12360-BIB0106|tri12360-cit-0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP1474","article-title":"Liver transient elastography (Fibroscan): a place in the management algorithms of chronic viral hepatitis","volume":"15","author":"Scott","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1111\/tri.12360-BIB0107|tri12360-cit-0107","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0b013e318273fec4","article-title":"Hepatitis C virus and nonliver solid organ transplantation","volume":"95","author":"Carbone","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0108|tri12360-cit-0108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/039493620601800307","article-title":"[Virus dell'epatite C nei pazienti in trattamento emodialitico in lista per trapianto di rene: l'esperienza di Padova.]","volume":"3","author":"Burra","year":"2006","journal-title":"Giornale di Techniche Nefrologiche & Dialitiche"},{"key":"10.1111\/tri.12360-BIB0109|tri12360-cit-0109","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12360-BIB0110|tri12360-cit-0110","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12360-BIB0111|tri12360-cit-0111","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/00007890-199611270-00007","article-title":"The long-term course of hepatitis C after kidney transplantation","volume":"62","author":"Kliem","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0112|tri12360-cit-0112","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(95)80279-7","article-title":"Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication","volume":"22","author":"Genesca","year":"1995","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12360-BIB0113|tri12360-cit-0113","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1097\/01.ASN.0000145896.16153.43","article-title":"Hepatitis C, acute humoral rejection, and renal allograft survival","volume":"15","author":"Forman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0114|tri12360-cit-0114","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00007890-200107270-00013","article-title":"Hepatitis C antibody status and outcomes in renal transplant recipients","volume":"72","author":"Meier-Kriesche","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0115|tri12360-cit-0115","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1600-6143.2005.00864.x","article-title":"Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12360-BIB0116|tri12360-cit-0116","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00007890-199610270-00004","article-title":"The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients","volume":"62","author":"Cosio","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0117|tri12360-cit-0117","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/00007890-199506270-00006","article-title":"De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients","volume":"59","author":"Roth","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0118|tri12360-cit-0118","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/00007890-199706150-00017","article-title":"Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients","volume":"63","author":"Morales","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0119|tri12360-cit-0119","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts","volume":"1","author":"Cruzado","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12360-BIB0120|tri12360-cit-0120","first-page":"247","article-title":"The impact of Hepatitis C virus infection on kidney transplantation outcomes: a systematic review of 18 observational studies: the impact of HCV on renal transplantation","volume":"11","author":"Rostami","year":"2011","journal-title":"Hepat Mon"},{"issue":"Suppl. 2","key":"10.1111\/tri.12360-BIB0121|tri12360-cit-0121","first-page":"ii41","article-title":"Renal transplantation in patients with hepatitis C virus antibody. A long national experience","volume":"3","author":"Morales","year":"2010","journal-title":"NDT Plus"},{"key":"10.1111\/tri.12360-BIB0122|tri12360-cit-0122","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0272-6386(95)90606-1","article-title":"Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases","volume":"26","author":"Gallay","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"Suppl. 4","key":"10.1111\/tri.12360-BIB0123|tri12360-cit-0123","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ndt\/11.supp4.54","article-title":"Glomerular disease during HCV infection in renal transplantation","volume":"11","author":"Hammoud","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0124|tri12360-cit-0124","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","article-title":"Hepatitis C infection and chronic renal diseases","volume":"4","author":"Perico","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0125|tri12360-cit-0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1681\/ASN.V101146","article-title":"Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients","volume":"10","author":"Baid","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12360-BIB0126|tri12360-cit-0126","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1046\/j.1523-1755.2003.00022.x","article-title":"Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy","volume":"63","author":"Rossi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12360-BIB0127|tri12360-cit-0127","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"key":"10.1111\/tri.12360-BIB0128|tri12360-cit-0128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/17.1.129","article-title":"Severe evolution of chronic hepatitis C in renal transplantation: a case control study","volume":"17","author":"Zylberberg","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0129|tri12360-cit-0129","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0168-8278(03)00358-1","article-title":"Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin","volume":"39","author":"Tang","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12360-BIB0130|tri12360-cit-0130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1399-0012.2006.00534.x","article-title":"Chronic hepatitis C virus infection in renal transplant: treatment and outcome","volume":"20","author":"Sharma","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.12360-BIB0131|tri12360-cit-0131","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/00007890-199811150-00023","article-title":"Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy","volume":"66","author":"Toth","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/tri.12360-BIB0132|tri12360-cit-0132","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0272-6386(98)70027-7","article-title":"Risk of death among chronic dialysis patients infected with hepatitis C virus","volume":"32","author":"Stehman-Breen","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0133|tri12360-cit-0133","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.transproceed.2010.04.056","article-title":"Kidney grafts from HCV-positive donors: advantages and disadvantages","volume":"42","author":"Maluf","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12360-BIB0134|tri12360-cit-0134","unstructured":"Gilead Sciences Inc. Sofosbuvir Product Monograph http:\/\/wwwgileadca\/pdf\/ca\/sovaldi_pm_english"},{"key":"10.1111\/tri.12360-BIB0135|tri12360-cit-0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2036.2003.01780.x","article-title":"Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients","volume":"18","author":"Fabrizi","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/tri.12360-BIB0136|tri12360-cit-0136","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1572-0241.2003.07526.x","article-title":"Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety","volume":"98","author":"Russo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/tri.12360-BIB0137|tri12360-cit-0137","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ndt\/gfi231","article-title":"Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C","volume":"21","author":"Russo","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0138|tri12360-cit-0138","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ndt\/gfh747","article-title":"Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients","volume":"20","author":"Teta","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12360-BIB0139|tri12360-cit-0139","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cgh.2010.10.018","article-title":"Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease","volume":"9","author":"Peck-Radosavljevic","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/tri.12360-BIB0140|tri12360-cit-0140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/j.ajkd.2013.03.037","article-title":"Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts","volume":"62","author":"Tseng","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.12360-BIB0141|tri12360-cit-0141","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3109\/0886022X.2013.826136","article-title":"Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience","volume":"35","author":"Alsaran","year":"2013","journal-title":"Ren Fail"},{"key":"10.1111\/tri.12360-BIB0142|tri12360-cit-0142","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-159-11-201312030-00005","article-title":"Pegylated interferon-alpha2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial","volume":"159","author":"Liu","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1111\/tri.12360-BIB0143|tri12360-cit-0143","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2014-307080","article-title":"Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial","author":"Liu","year":"2014","journal-title":"Gut"},{"key":"10.1111\/tri.12360-BIB0144|tri12360-cit-0144","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.dld.2013.08.133","article-title":"Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation","volume":"46","author":"Knapstein","year":"2014","journal-title":"Dig Liver Dis"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12360","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12360\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T22:13:10Z","timestamp":1716761590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":144,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12360","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}